Benign prostatic hyperplasia (BPH) is frequently observed in intact middle-aged or older male dogs with symptoms ranging from asymptomatic to various symptoms such as urination, dyschezia, dysuria, tenesmus, and intermittent serosanguinous or clear serous exudate. A 4-year-old, intact male Welsh corgi with symptoms of intermittent hematuria and serosanguinous exudate at the urethral opening was diagnosed with BPH and intraprostatic hematocyst through ultrasonographic examination and cytology test. The dog was internationally adopted for reproductive purposes and needed to undergo BPH treatment while maintaining fertility. Thus, 2.5 mg finasteride was administered orally once a day for treatment option and therapeutic effects were observed, including loss of clinical symptoms and reduced prostate and intraparenchymal cyst size.

The lower urinary tract symptoms (LUTS) show in benign prostatic hyperplasia (BPH). The three major micturition centers in brain are pontine micturition center (PMC), ventrolateral periaqueductal gray (vlPAG), and medial preopticnucleus (MPA) regions. Previous study showed that c-Fos expression change was associated with LUTS. In present study, the effect of P. ginseng on c-Fos expression in PMC, vlPAG, and MPA regions in rat brain was tested. P. ginseng is the four year-old Korean ginseng. It was collected at the department of medicinal crop research (Eumsunggun, Chungbuk, Korea) in September 2010. The four groups (n = 6) are control group, BPH-induced group, BPHinduced and P. ginseng-treated group, and BPH-induced and finasteride-treated group. BPH in rats was induced by testosterone. After 4 weeks, all animals were sacrificed to evaluate c-Fos expression in PMC, vlPAG, and MPA regions in rat brain. The c-Fos expression was evaluated in the regions of rat brain by immunohistochemistry (IHC). Present results showed that c-Fos expressions in PMC, vl-PAG, and MPA regions in brain of rats in the BPH-induced group were higher compared to c-fos expression of the control group. The increased c-Fos expression in three regions (PMC, vlPAG, and MPA) were decreased by treatment with P. ginseng (200 mg/kg). These results suggest that P. ginseng has an inhibitory effect on the symptoms of BPH and is associated with regulation of c-Fos expression in the brain in a testosterone induced BPH rat model.

We evaluated the efficacy and safety of plasmakinetic transurethral enucleation and resection (TUERP) for benign prostatic hyperplasia (BPH) more than 80g. From January 2011 to December 2013, 37 patients with BPH larger than 80 g who underwent plasmakinetic TUERP were retrospectively assessed. The postoperative outcomes such as operative time, resected adenoma weight, resection rate, catheterization time, postoperative hospital stay and complications were reviewed. Patients were followed up at 1, 3, 6 months postoperatively. The mean prostate volume was 108.7 ± 21.7 g (range, 80 to 200 g), The mean resection chip weight was 53.5 ± 15.7 g (range, 29 to 101 g), The mean resection ratio was 82.0 ± 12.9%. Catheterization time and hospital stay was 2.4 ± 1.6 days and 3.4 ± 1.6 days respectively. Perioperative loss of hemoglobin and serum sodium was 1.5 ± 0.8 g/dL and 2.3 ±2.0 mmol/L respectively. International Prostate Symptom Score (IPSS), quality of life (QOL) score, maximum flow rate (Qmax), post void residual urine volume (PVR) were significantly improved at all followup intervals compared with baseline. No major complication including TUR syndrome was developed. Plasmakinetic TUERP is considered a safe, effective and technically feasible procedure for the large volume BPH more than 80 g at shortterm followup.